Share of Cost, Deterioration in a Husband’s Health Likely When Wife Suffers Breast Cancer
Thursday, Dec. 27th 2012 4:12 PM
Caring for a wife with breast cancer can have a measurable negative effect on men’s health, even years after the cancer diagnosis and completion of treatment, according to recent research. Men who reported the highest levels of stress in relation to their wives’ cancer were at the highest risk for physical symptoms and weaker immune responses, the study showed.
Related posts:
- California Share of Cost, Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found California Share of Cost, Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found: After new scientific evidence revealed a possible link between food dyes and childhood cancer and hyperactivity, Australian food authorities are reported to be considering banning food colorings from breakfast cereals and confectionary items. The research […]...
- Trauma, Abuse In Childhood Linked To Shorter Lifespan, Weaker Immune Response Later In Life New research from the US suggests that trauma in childhood such as experiencing abuse or a serious stressful event like losing a parent is linked to a shorter lifespan and weaker immune system later in life, and that the immune impairment even adds to that caused by the stress of caring for a family member […]...
- Share of Cost, TU Delft Develops Pen To Measure And Reduce Stress Share of Cost, TU Delft Develops Pen To Measure And Reduce Stress...
- Stress Could Decrease Women’s Chances Of Conceiving, Study Reports Women with elevated stress levels might be less likely to get pregnant, according to a study published recently in the journal Fertility and Sterility USA Today reported today....
- Researchers Find More Evidence That Malaria Drug Could Help Combat Cancer, And That Breaks From Treatment Could Improve Results Scientists investigating the cancer-fighting properties of artesunate a drug commonly used to treat malaria have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels. The findings, recently published in […]...
- Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Share of Cost, For Acid Reflux Disease Patients, Esophageal Cancer Risk Lower Than Expected Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Share of Cost, Diagnostic Criteria For Posttraumatic Stress Disorder Are Lacking According To Researchers Share of Cost, Diagnostic Criteria For Posttraumatic Stress Disorder Are Lacking According To Researchers...
- Share of Cost: City And Country People’s Brain Structures Respond Differently To Social Stress We all knew that city dwellers are more susceptible to mental disorders than their rural counterparts – a new study has shown that specific brain structures respond differently to social stress, depending on whether you are an urban or countryside dweller, researchers from the University of Heidelberg’s Central Institute of Mental Health, Mannheim, Germany, reported […]...
- When Budgets Are Tight, There Are Better Options Than Colonoscopies For Colorectal Cancer Screening [Web First] A critical challenge facing cancer screening programs, particularly those aimed at uninsured people with low incomes, is choosing the screening test that makes the most efficient use of limited budgets. For colorectal cancer screening, there is growing momentum to use colonoscopy, which is an expensive test. In this study, we modeled scenarios to assess whether […]...
- Asthma And Eczema Sufferers Have A Lower Risk Of Developing A Cancer Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRS Institut Armand-Frappier, the Research Centre of the Centre hospitalier de l’Université de Montréal, and McGill University…...
- Homing In On Genetic Signature Of Esophageal Cancer University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes. The study, led by Tony Godfrey, Ph.D., a research associate professor of Surgery at the James P....
- Share of Cost, Medi-Cal, Also In Global Health News: HIV In Cities; NIH Director’s Role In Global Health; Access To Healthcare In Kenya; Food Aid In Ethiopia; More UNAIDS Calls On Cities To Enhance Response To HIV; China Vows To Step Up Prevention UNAIDS has “issued a call for cities to ‘take the lead in making HIV history’ by enhancing their response to the epidemic,” UN News Centre reports....
- Share of Cost, Multipolar Electrocoagulation Ablation Shown To Be Effective For Barrett’s Esophagus In Long-Term Follow-Up A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett’s esophagus over the long term. No adenocarcinoma (cancer) or high-grade dysplasia of the esophagus developed in any of the study patients....
- Share of Cost, Einstein Receives $4 Million To Test HPV Microbicide Share of Cost, Einstein Receives $4 Million To Test HPV Microbicide — The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from […]...
Posted on Thursday, Dec. 27th 2012 4:12 PM | by Share of Cost | in Share of Cost | No Comments »